Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Eisai Co., Ltd.
  6. Company
    4523   JP3160400002

EISAI CO., LTD.

(4523)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Eisai Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research and development, manufacture, sale, import and export of pharmaceuticals. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Oceania), Asia and Latin America (South Korea, Taiwan, Hong Kong, India, ASEAN, Latin America). The Others segment is involved in license revenues and pharmaceutical raw materials business. The Company is also engaged in the provision of brands such as the anticancer drugs Lembima and Halaven on the nerve and oncology areas.

Number of employees : 11 237 people.
Sales per Business
20202021Delta
Pharmaceutical577 267.0083%586 060.0090.7% +1.52%
Other118 355.0017%59 881.009.3% -49.41%
JPY in Million
Sales per region
20202021Delta
Japan279 696.0040.2%263 520.0040.8% -5.78%
Americas160 773.0023.1%160 433.0024.8% -0.21%
Europe128 962.0018.5%87 562.0013.6% -32.1%
China77 386.0011.1%84 883.0013.1% +9.69%
Other48 804.007%49 544.007.7% +1.52%
JPY in Million
Managers
Name Title Age Since
Haruo Naito Chief Executive Officer & Representative Director 73 2014
Ryohei Yanagi Chief Financial Officer 59 2020
Edward Stewart Geary Chief Medical Officer & Managing Executive Officer 58 2013
Lynn Kramer Chief Medical & Chief Clinical Officer-Neurology 70 2016
Yasushi Okada COO, Representative Executive Officer & Head-China 62 2019
Mitsuaki Tanaka Chief Compliance & Information Security Officer 59 2020
Yasuhiko Katoh Chairman 74 2018
Tamaki Kakizaki Independent Outside Director 60 2016
Daiken Tsunoda Independent Outside Director 54 2016
Bruce Aronson Independent Outside Director 69 2017
Members of the board
Name Title Age Since
Yasuhiko Katoh Chairman 74 2018
Haruo Naito Chief Executive Officer & Representative Director 73 2014
Hideki Hayashi Director 63 2019
Yutaka Tsuchiya Director 69 2017
Tamaki Kakizaki Independent Outside Director 60 2016
Daiken Tsunoda Independent Outside Director 54 2016
Bruce Aronson Independent Outside Director 69 2017
Shuzo Kaihori Independent Outside Director 73 2018
Ryuichi Murata Independent Outside Director 73 2018
Hideyo Uchiyama Independent Outside Director 68 2018
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0.01 296,566,949 260,653,303 87.9% 9,826,160 3.3% 87.9%
Shareholders
NameEquities%
Wellington Management Co. LLP 25,598,248 8.63%
Nomura Asset Management Co., Ltd. 18,292,900 6.17%
Government of Japan 14,945,200 5.04%
Nippon Life Insurance Co. 11,540,045 3.89%
Asset Management One Co., Ltd. 10,341,206 3.49%
Eisai Co., Ltd. 9,839,000 3.32%
Daiwa Asset Management Co. Ltd. 8,604,695 2.90%
Nikko Asset Management Co., Ltd. 8,549,598 2.88%
The Vanguard Group, Inc. 6,558,333 2.21%
Resona Holdings, Inc. 6,300,000 2.12%
Holdings
NameEquities%Valuation
EISAI CO., LTD. (4523) 9,839,000 3.32% 813,737,053 USD
MATSUMOTOKIYOSHI HOLDINGS CO., LTD. (3088) 2,815,000 2.58% 130,679,957 USD
ALFRESA HOLDINGS CORPORATION (2784) 3,452,724 1.47% 54,716,836 USD
SUZUKEN CO., LTD. (9987) 1,040,945 1.01% 30,983,894 USD
COGSTATE LIMITED (CGS) 11,738,243 6.86% 14,541,218 USD
KISSEI PHARMACEUTICAL CO., LTD. (4547) 474,000 0.91% 10,449,918 USD
VITAL KSK HOLDINGS, INC. (3151) 642,154 1.05% 4,752,152 USD
HOKUYAKU TAKEYAMA HOLDINGS,INC. (3055) 546,005 2.24% 3,578,408 USD
MEDIPAL HOLDINGS CORPORATION (7459) 125,100 0.051% 2,394,733 USD
SYMBIO PHARMACEUTICALS LIMITED (4582) 208,350 0.54% 2,033,052 USD
Markets and indexes
- First Section
- Nikkei 225 /
Stock Exchange Codes
- Bloomberg Code :  4523:JP
- Reuters Code :  4523.T
- Datastream Code :  
Company contact information
Eisai Co., Ltd.
4-6-10 Koishikawa
JP-112-8088 Bunkyo-ku, Tokyo

Phone : +81 3 3817 3700
Fax :
web site : https://www.eisai.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Eisai Co., Ltd.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
EISAI CO., LTD.13.17%21 808
JOHNSON & JOHNSON4.98%434 939
ROCHE HOLDING AG11.70%327 062
PFIZER, INC.21.62%249 329
NOVO NORDISK A/S51.34%233 887
ELI LILLY AND COMPANY36.84%209 456
ABBVIE INC.0.87%190 996
NOVARTIS AG-6.89%188 323
MERCK & CO., INC.-12.02%182 183
ASTRAZENECA PLC11.16%173 735
BRISTOL-MYERS SQUIBB COMPANY-1.29%136 060
AMGEN INC.-5.46%123 428
SANOFI3.77%120 604
GLAXOSMITHKLINE PLC3.95%96 182
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-25.00%61 871
TAKEDA PHARMACEUTICAL COMPANY LIMITED0.67%54 198
BAYER AG-5.22%52 750
DAIICHI SANKYO COMPANY, LIMITED-21.67%48 385
JIANGSU HENGRUI MEDICINE CO., LTD.-50.31%45 545
ASTELLAS PHARMA INC.18.10%31 807